Abimbola Lawal contributes to all ongoing laboratory projects focused on understanding therapy resistance in acute myeloid leukemia (AML), with particular emphasis on mechanisms involving splicing, cellular quiescence, and differentiation. To support these efforts, she conducts a range of in vitro and in vivo assays.
